Agency Business briefs: October 2013

Share this article:
Blair Robertson
Blair Robertson
Intouch Solutions launched Intouch Science, which will be dedicated to HCP-centric messaging.The company said in a statement that the unit will combine clinical guidance and technological insight. The team includes medical director James Haupt and director of healthcare professional insights Bunny Ellerin.

Blair Roberston has joined Cambridge BioMarketing as its first chief strategy officer. Roberston joins the firm after a two-year stint as Cambrooke Inc.'s chief commercial officer where he led global marketing, communications, sales and medical affairs.

Peter Mollegard is MedEvoke's new senior director of client service. Mollegard will be in charge of the client service and project management teams. The company said in a statement that the new exec's focus includes making its ISIS methodology the pharma industry standard operating procedure.

San Francisco-based digital healthcare agency Eveo
opened its first ex-US office. VP and group account director Chelsea Goodman will head the London office. Goodman will be joined by VP and business development director Colin Wheeler who is coming over from M2 Worldwide.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.